title: Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.
authors.affiliation: All authors: National Cancer Institute, Bethesda, MD. sb16i@nih.gov.
authors.forename: Stuart G
authors.initials: SG
authors.lastname: Baker
authors.affiliation: All authors: National Cancer Institute, Bethesda, MD.
authors.forename: Barnett S
authors.initials: BS
authors.lastname: Kramer
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000453:epidemiology* / Q000473:pathology; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D015994:Incidence; D008432:Mathematical Computing; D015233:Models, Statistical; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009369:Neoplasms / Q000453:epidemiology; D016017:Odds Ratio; D011237:Predictive Value of Tests; D011379:Prognosis; D012372:ROC Curve; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor